PACDB provides the information on pathogens (e.g. bacteria, fungus, toxin and virus) adhering to carbohydrates expressed on the cell surface of host animals or plants.
Database | Last Updated |
---|---|
Pathogen Adherence to Carbohydrate Database (PACDB) | June 1, 2016 |
Species | Pathogen Adherence Molecule | Ligand Name | Ligand Feature | Target Source ▲ | Glycan Sequence | Binding | PubMed ID |
---|---|---|---|---|---|---|---|
Fimbriae
|
Asialo GM1 (Gangliotetraosylceramide; Gg4; GA1)
|
Oligoglycosylceramides
|
Gal(b1-3)GalNAc(b1-4)Gal(b1-4)Glc(b1-1)Cer
|
Binding
|
|||
Fimbriae
|
Gb3 (Globotriaosylceramide; Trihexosylceramide; Pk antigen (GSL); CTH)
|
Oligoglycosylceramides
|
Gal(a1-4)Gal(b1-4)Glc(b1-1)Cer
|
Binding
|
|||
Fimbriae
|
Asialo GM1 (Gangliotetraosylceramide; Gg4; GA1)
|
Oligoglycosylceramides
|
Gal(b1-3)GalNAc(b1-4)Gal(b1-4)Glc(b1-1)Cer
|
Binding
|
|||
P-fimbriae
|
Gb3 (Globotriaosylceramide; Trihexosylceramide; Pk antigen (GSL); CTH)
|
Oligoglycosylceramides
|
Gal(a1-4)Gal(b1-4)Glc(b1-1)Cer
|
Binding
|
|||
P-fimbriae
|
Gb3 (Globotriaosylceramide; Trihexosylceramide; Pk antigen (GSL); CTH)
|
Oligoglycosylceramides
|
Gal(a1-4)Gal(b1-4)Glc(b1-1)Cer
|
Not Binding
|
|||
P-fimbriae
|
unnamed ligand
|
Oligoglycosylceramides
|
Gal(b1-4)[Fuc(a1-3)]GlcNAc(b1-6)[Gal(b1-3)]GalNAc(b1-3)Gal(a1-4)Gal(b1-4)Glc(b1-1)Cer
|
Binding
|
|||
P-fimbriae
|
Gb3 (Globotriaosylceramide; Trihexosylceramide; Pk antigen (GSL); CTH)
|
Oligoglycosylceramides
|
Gal(a1-4)Gal(b1-4)Glc(b1-1)Cer
|
Binding
|
|||
P-pili
|
Gb3 (Globotriaosylceramide; Trihexosylceramide; Pk antigen (GSL); CTH)
|
Oligoglycosylceramides
|
Gal(a1-4)Gal(b1-4)Glc(b1-1)Cer
|
Binding
|
|||
Type 4-pili
|
Asialo GM1 (Gangliotetraosylceramide; Gg4; GA1)
|
Oligoglycosylceramides
|
Gal(b1-3)GalNAc(b1-4)Gal(b1-4)Glc(b1-1)Cer
|
Binding
|
|||
Cholera toxin
|
Asialo GM1 (Gangliotetraosylceramide; Gg4; GA1)
|
Oligoglycosylceramides
|
Gal(b1-3)GalNAc(b1-4)Gal(b1-4)Glc(b1-1)Cer
|
Not Binding
|
GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.
Supported by JST NBDC Grant Number JPMJND2204
Partly supported by NIH Common Fund Grant #1U01GM125267-01